OAB-051: Daratumumab, Carfilzomib, Lenalidomide and Dexamethasone (Dara-KRd), autologous transplantation and MRD response-adapted treatment duration and cessation in newly diagnosed Multiple Myeloma (NDMM)
作者
Luciano J. Costa,Saurabh Chhabra,Eva Medvedova,Bhagirathbhai Dholaria,Timothy Martin Schmidt,Rebecca Wang Silbermann,Kelly Nicole Godby,Binod Dhakal,Susan Bal,Smith Giri,Anita D’Souza,Robert Frank Cornell,Pamela Hardwick,James L. Omel,Parameswaran Hari,Natalie S. Callander